Lack of evidence for use of glatiramer acetate in multiple sclerosis

Lancet Neurol. 2004 Nov;3(11):641. doi: 10.1016/S1474-4422(04)00899-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Evidence-Based Medicine
  • Glatiramer Acetate
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / epidemiology
  • Peptides / therapeutic use*
  • Randomized Controlled Trials as Topic*

Substances

  • Peptides
  • Glatiramer Acetate